BridgeMD
New treatment option for Shoulder Pain
Official title Effects of Rigid Taping in Acromioclavicular Joint Degeneration
ClinicalTrials.gov ID: NCT07333417
What this study is testing
- What it's testing
- This study will examine whether rigid taping applied to the acromioclavicular (AC) joint can reduce shoulder pain and improve shoulder function in people with AC joint degeneration. Participants with shoulder pain and a confirmed diagnosis of AC joint degeneration will be randomly assigned to one of two groups: (1) rigid taping plus a standardized exercise program or (2) the same exercise program without taping.
- Time commitment: about 4 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- A clinical diagnosis of acromioclavicular (AC) joint degeneration confirmed by clinical examination and imaging (X-ray, ultrasound, or MRI).
- Shoulder pain duration of at least 4 weeks.
- Age between 18 and 65 years
- Willingness to refrain from any additional treatments outside the study protocol during the study period (e.g., medication changes, injections, or...
You likely can't join if
- Current or previous diagnosis/history of acromioclavicular (AC) joint separation.
- Diagnosis of frozen shoulder (adhesive capsulitis).
- History of acute trauma or fracture involving the shoulder girdle (e.g., clavicle fracture, shoulder dislocation).
- History of shoulder surgery.
- Systemic inflammatory joint disease (e.g., rheumatoid arthritis) or other systemic arthropathies.
- Skin conditions preventing taping (e.g., rash, open wound, or known tape allergy).
See the full eligibility criteria
- A clinical diagnosis of acromioclavicular (AC) joint degeneration confirmed by clinical examination and imaging (X-ray, ultrasound, or MRI).
- Shoulder pain duration of at least 4 weeks.
- Age between 18 and 65 years
- Willingness to refrain from any additional treatments outside the study protocol during the study period (e.g., medication changes, injections, or physiotherapy elsewhere) and to provide written informed consent
- Current or previous diagnosis/history of acromioclavicular (AC) joint separation.
- Diagnosis of frozen shoulder (adhesive capsulitis).
- History of acute trauma or fracture involving the shoulder girdle (e.g., clavicle fracture, shoulder dislocation).
- History of shoulder surgery.
- Systemic inflammatory joint disease (e.g., rheumatoid arthritis) or other systemic arthropathies.
- Skin conditions preventing taping (e.g., rash, open wound, or known tape allergy).
- Neuromuscular disease or neurological disorders affecting shoulder function
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.